Helou J - Search Results

1

Extended Results and Independent Validation of a Phase 2 Trial of Metastasis-Directed Therapy for Molecularly Defined Oligometastatic Prostate Cancer.

Glicksman RM, Ramotar M, Metser U, Chung PW, Liu Z, Vines D, Finelli A, Hamilton R, Fleshner NE, Perlis N, Zlotta AR, Bayley A, Helou J, Raman S, Kulkarni G, Catton C, Lam T, Chan R, Warde P, Gospodarowicz M, Jaffray DA, Berlin A. Glicksman RM, et al. Among authors: helou j. Int J Radiat Oncol Biol Phys. 2022 Nov 15;114(4):693-704. doi: 10.1016/j.ijrobp.2022.06.080. Epub 2022 Aug 27. Int J Radiat Oncol Biol Phys. 2022. PMID: 36031465 Clinical Trial.

2

The clinical significance of persistent cancer cells on prostate biopsy after high-dose-rate brachytherapy boost for intermediate-risk prostate cancer.

D'Alimonte L, Helou J, Sherman C, Loblaw A, Chung HT, Ravi A, Deabreu A, Zhang L, Morton G. D'Alimonte L, et al. Among authors: helou j. Brachytherapy. 2015 May-Jun;14(3):309-14. doi: 10.1016/j.brachy.2014.10.003. Epub 2014 Nov 25. Brachytherapy. 2015. PMID: 25466361

3

Predictive Parameters of Symptomatic Hematochezia Following 5-Fraction Gantry-Based SABR in Prostate Cancer.

Musunuru HB, Davidson M, Cheung P, Vesprini D, Liu S, Chung H, Chu W, Mamedov A, Ravi A, D'Alimonte L, Commisso K, Helou J, Deabreu A, Zhang L, Loblaw A. Musunuru HB, et al. Among authors: helou j. Int J Radiat Oncol Biol Phys. 2016 Apr 1;94(5):1043-51. doi: 10.1016/j.ijrobp.2015.12.010. Epub 2015 Dec 23. Int J Radiat Oncol Biol Phys. 2016. PMID: 27026311 Clinical Trial.

4

Evaluation of a Machine-Learning Algorithm for Treatment Planning in Prostate Low-Dose-Rate Brachytherapy.

Nicolae A, Morton G, Chung H, Loblaw A, Jain S, Mitchell D, Lu L, Helou J, Al-Hanaqta M, Heath E, Ravi A. Nicolae A, et al. Among authors: helou j. Int J Radiat Oncol Biol Phys. 2017 Mar 15;97(4):822-829. doi: 10.1016/j.ijrobp.2016.11.036. Epub 2016 Nov 27. Int J Radiat Oncol Biol Phys. 2017. PMID: 28244419

5

Stereotactic ablative radiotherapy in the treatment of low and intermediate risk prostate cancer: Is there an optimal dose?

Helou J, D'Alimonte L, Quon H, Deabreu A, Commisso K, Cheung P, Chu W, Mamedov A, Davidson M, Ravi A, Loblaw A. Helou J, et al. Radiother Oncol. 2017 Jun;123(3):478-482. doi: 10.1016/j.radonc.2017.03.006. Epub 2017 Apr 19. Radiother Oncol. 2017. PMID: 28433413

6

Stereotactic Ablative Radiation Therapy for Pulmonary Metastases: Histology, Dose, and Indication Matter.

Helou J, Thibault I, Poon I, Chiang A, Jain S, Soliman H, Erler D, Yeung L, Cheung P. Helou J, et al. Int J Radiat Oncol Biol Phys. 2017 Jun 1;98(2):419-427. doi: 10.1016/j.ijrobp.2017.02.093. Epub 2017 Feb 28. Int J Radiat Oncol Biol Phys. 2017. PMID: 28463162

7

Dosimetric impact of intrafraction changes in MR-guided high-dose-rate (HDR) brachytherapy for prostate cancer.

Rink A, Borg J, Simeonov A, O'Leary G, Helou J, Ménard C, Chung P, Jaffray DA, Berlin A. Rink A, et al. Among authors: helou j. Brachytherapy. 2018 Jan-Feb;17(1):59-67. doi: 10.1016/j.brachy.2017.06.001. Epub 2017 Jul 29. Brachytherapy. 2018. PMID: 28764881

8

Use of hydrogel spacer for improved rectal dose-sparing in patients undergoing radical radiotherapy for localized prostate cancer: First Canadian experience.

Berlin A, Di Tomasso A, Ballantyne H, Patterson S, Lam T, Sundaramurthy A, Helou J, Bayley A, Chung P. Berlin A, et al. Among authors: helou j. Can Urol Assoc J. 2017 Dec;11(12):373-375. doi: 10.5489/cuaj.4681. Epub 2017 Nov 1. Can Urol Assoc J. 2017. PMID: 29257741 Free PMC article.

9

Dose escalation for prostate stereotactic ablative radiotherapy (SABR): Late outcomes from two prospective clinical trials.

Alayed Y, Cheung P, Pang G, Mamedov A, D'Alimonte L, Deabreu A, Commisso K, Commisso A, Zhang L, Quon HC, Musunuru HB, Helou J, Loblaw DA. Alayed Y, et al. Among authors: helou j. Radiother Oncol. 2018 May;127(2):213-218. doi: 10.1016/j.radonc.2018.03.005. Epub 2018 Mar 24. Radiother Oncol. 2018. PMID: 29588072 Clinical Trial.

10

[Definitions of oligometastatic disease and new treatment concepts].

Kissel M, Helou J, Thariat J. Kissel M, et al. Among authors: helou j. Bull Cancer. 2018 Jul-Aug;105(7-8):696-706. doi: 10.1016/j.bulcan.2018.04.012. Epub 2018 Jun 20. Bull Cancer. 2018. PMID: 29935914 Review. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

194 results

Search Page

Filters